Cannabis Research Funding Landscape Updates – March 2026
This update covers the cannabis research funding landscape and its impact on clinical and regulatory developments. Market expansion into minor cannabinoids and retail normalization are key themes. Enforcement patterns and psychoactive substance…
Federal Marijuana Rescheduling May Speed Tennessee MMJ Legalization
Federal marijuana rescheduling Tennessee medical cannabis could remove barriers to clinical research and accelerate legalization in Tennessee. This shift allows clinicians to access evidence-based data for patient care. It also enables a legal framework…
Cannabis Industry Regulatory Challenges in 2026
This article reviews cannabis industry regulatory challenges including enforcement actions and roadside THC testing accuracy. It covers hemp product regulation and retail expansion trends. These topics highlight evolving cannabis policy enforcement in…
Regulatory Digest: Rescheduling Marijuana and Controlled Substances
The controlled substances rescheduling 2026 marks a pivotal regulatory update enabling more rigorous clinical trials and research. This change may facilitate evidence-based guidelines for marijuana use. Clinicians should prepare for evolving policies as…
